We are live on
!
Find out more
SCM
Scopia Capital Management Portfolio holdings
AUM
$112M
1-Year Est. Return
48.41%
This Fund
S&P 500
This Quarter
Est. Return
+1.64%
1 Year Est. Return
+48.41%
3 Year Est. Return
+58.7%
5 Year Est. Return
+80.15%
10 Year Est. Return
+533.22%
AUM
$5.57B
AUM Growth
-$750M
(-12%)
Cap. Flow
-$17.4M
Cap. Flow
% of AUM
-0.31%
Top 10 Holdings %
Top 10 Hldgs %
61.49%
Holding
37
New
5
Increased
12
Reduced
9
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$131M |
| 2 |
AUD
Audacy, Inc.
AUD
|
+$122M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$110M |
| 4 |
ISBC
Investors Bancorp, Inc.
ISBC
|
+$82.9M |
| 5 |
Plains GP Holdings
PAGP
|
+$81.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPR
Spirit AeroSystems
SPR
|
+$179M |
| 2 |
Baidu
BIDU
|
+$151M |
| 3 |
AAAP
Advanced Accelerator Applications S.A.
AAAP
|
+$135M |
| 4 |
CNX Resources
CNX
|
+$107M |
| 5 |
Fidelity National Financial
FNF
|
+$77.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.9% |
| 2 | Industrials | 15.5% |
| 3 | Communication Services | 13.9% |
| 4 | Real Estate | 13.75% |
| 5 | Energy | 7.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
PTC Therapeutics
PTCT
$5.48B
| $69.1M | 1.24% |
4,143,270
+2,949,141
| +247% | +$49.9M |
|
27
Equifax
EFX
$19.6B
| $56.8M | 1.02% |
481,812
-39,812
| -8% | -$4.48M |
|
|
TMH
28
DELISTED
Team Health Holdings Inc
TMH
| $23.4M | 0.42% |
3,338,649
| – | – |
|
|
AAAP
29
DELISTED
Advanced Accelerator Applications S.A.
AAAP
| $12M | 0.22% |
147,404
-1,741,739
| -92% | -$135M |
|
|
RDUS
30
DELISTED
Radius Health, Inc.
RDUS
| $7.39M | 0.13% |
+232,635
| New | +$7.3M |
|
31
American Superconductor
AMSC
$1.34B
| – | – |
-19,610
| Closed | -$89K |
|
|
32
CNX Resources
CNX
$5.24B
| – | – |
-7,549,765
| Closed | -$107M |
|
|
33
Fidelity National Financial
FNF
$11.7B
| – | – |
-2,351,369
| Closed | -$77.5M |
|
34
Fossil Group
FOSL
$298M
| – | – |
-395,925
| Closed | -$3.69M |
|
35
MannKind Corp
MNKD
$1.14B
| – | – |
-982,930
| Closed | -$2.13M |
|
36
Prospect Capital
PSEC
$1.14B
| – | – |
-104,194
| Closed | -$700K |
|
|
NDRM
37
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| – | – |
-205,358
| Closed | -$7.99M |
|
Similar funds
SWM
TFS
WAM
CS
BU
TBFA
VDC
RQS
Scopia Capital Management's Q4 2017 Portfolio in Review
As of Q4 2017, Scopia Capital Management held 37 positions worth $5.57B, down 12% from $6.32B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Scopia Capital Management's Q4 2017 filing shows 5 new, 12 increased, 9 reduced and 7 closed positions. Its largest new stake was Zogenix, Inc.: 3,420,599 shares worth $137M. The largest sale was Spirit AeroSystems, an estimated $179M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 21% a quarter earlier, followed by Industrials and Communication Services.
- Scopia Capital Management's largest Q4 2017 buy was Zogenix, Inc.: 3,420,599 shares worth $137M.
- Scopia Capital Management added most to Audacy, Inc. in Q4 2017, an estimated $122M increase.
- Scopia Capital Management's biggest Q4 2017 reduction was Spirit AeroSystems, cutting an estimated $179M.
- Scopia Capital Management fully exited CNX Resources in Q4 2017, selling an estimated $107M.
- Scopia Capital Management's ten largest holdings make up 61% of its $5.57B portfolio in Q4 2017.
- Scopia Capital Management opened 5 new positions and closed 7 in Q4 2017.
- Scopia Capital Management's portfolio value fell 12% quarter-over-quarter to $5.57B.
Based on Scopia Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.